Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A phase 1 trial of HLA-DR matched third party donor-derived fungus-specific cytotoxic T-lymphocytes in patients with invasive fungal disease post-allogeneic stem cell transplantation
Protocol ID
R3ACT Fungal
Disease (Sub Disease)
Invasive Fungal Disease
Diagnosis Stage
Newly diagnosed
Relapsed/Refractory
Relapsed/Refractory
Location
NSW
Sponsor
Western Sydney Local Health District
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
Study Type
Treatment
Phase
Phase 1
Age Eligibility
1 Years to 80 Years
ANZCTR
ACTRN12618001540202
| Study Title | A phase 1 trial of HLA-DR matched third party donor-derived fungus-specific cytotoxic T-lymphocytes in patients with invasive fungal disease post-allogeneic stem cell transplantation |
|---|---|
| Protocol ID | R3ACT Fungal |
| Disease (Sub Disease) | Invasive Fungal Disease |
| Diagnosis Stage | Newly diagnosed Relapsed/Refractory |
| Location | NSW |
| Sponsor | Western Sydney Local Health District |
| Links | https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=375583&isReview=true |
| Trial Status | Open |
| Trial Open Date | 19/08/2019 |
| Sites | The Children's Hospital at Westmead |
| Study Type | Treatment |
| Phase | Phase 1 |
| Age Eligibility | 1 Years to 80 Years |
| ANZCTR | ACTRN12618001540202 |